Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Status: Enrolling
Updated:  2/21/2018
Heart Associates
mi
from
Youngstown, OH
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Status: Enrolling
Updated: 2/21/2018
Heart Associates
mi
from
Youngstown, OH
Click here to add this to my saved trials
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
To Define the Role of PDEV in Mediating the Decreased GFR and Attenuated Renal Sodium and cGMP Excretory Response to Acute Saline Volume Expansion in PSD and PDD With Renal Dysfunction.
Status: Enrolling
Updated:  2/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
To Define the Role of PDEV in Mediating the Decreased GFR and Attenuated Renal Sodium and cGMP Excretory Response to Acute Saline Volume Expansion in PSD and PDD With Renal Dysfunction.
Status: Enrolling
Updated: 2/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated:  2/27/2018
Vanderbilt University
mi
from
Nashville, TN
The Autonomic Nervous System and Obesity
The Autonomic Nervous System and Obesity
Status: Enrolling
Updated: 2/27/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Beverages and Societal Health
Sugar Sweetened Beverages And Cardiovascular Disease Risk
Status: Enrolling
Updated:  2/27/2018
Children's Hospital Boston
mi
from
Boston, MA
Beverages and Societal Health
Sugar Sweetened Beverages And Cardiovascular Disease Risk
Status: Enrolling
Updated: 2/27/2018
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Apex Cardiology Consultants
mi
from
Inglewood, CA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Apex Cardiology Consultants
mi
from
Inglewood, CA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
St Francis Hospital and Medical Center
mi
from
Hartford, CT
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
St Francis Hospital and Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Orlando Regional Medical Center
mi
from
Orlando, FL
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Orlando Regional Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Florida Cardiovascular Institute
mi
from
Tampa, FL
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Florida Cardiovascular Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
The Care Group, LLC
mi
from
Indianapolis, IN
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Liberty Cardiovascular Specialists
mi
from
Liberty, MO
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Liberty Cardiovascular Specialists
mi
from
Liberty, MO
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Forsyth Cardiovascular Research
mi
from
Winston-Salem, NC
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Forsyth Cardiovascular Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Ohio State University
mi
from
Columbus, OH
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Medical University of South Carolina
mi
from
Charleston, SC
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Cardiology Associates of Mobile
mi
from
Mobile, AL
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Cardiology Associates of Mobile
mi
from
Mobile, AL
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
University of Southern California
mi
from
Los Angeles, CA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Florida Hospital Cardiovascular Institute/Florida Heart Group
mi
from
Orlando, FL
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Florida Hospital Cardiovascular Institute/Florida Heart Group
mi
from
Orlando, FL
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Heart and Vascular Institute of Florida
mi
from
Saint Petersburg, FL
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Heart and Vascular Institute of Florida
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Cardiovascular Institute of the South
mi
from
Houma, LA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Washington University
mi
from
Saint Louis, MO
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
The Lindner Research Center
mi
from
Cincinnati, OH
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
The Lindner Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Northwest Ohio Cardiology Consultants
mi
from
Toledo, OH
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Northwest Ohio Cardiology Consultants
mi
from
Toledo, OH
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Drexel University
mi
from
Philadelphia, PA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated:  2/27/2018
Allegheny General Hospital
mi
from
Pittsburgh, PA
Rheos HOPE4HF (Health Outcomes Prospective Evaluation for Heart Failure With Ejection Fraction (EF) ≥ 40%) Trial
Health Outcomes Prospective Evaluation for Heart Failure With EF ≥ 40%
Status: Enrolling
Updated: 2/27/2018
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Scripps Health
mi
from
La Jolla, CA
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Scripps Health
mi
from
La Jolla, CA
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
CardioVascular Solutions Institute
mi
from
Bradenton, FL
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
CardioVascular Solutions Institute
mi
from
Bradenton, FL
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
University of Louisville
mi
from
Louisville, KY
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
New York Presbyterian-Weill Cornell Medical Center
mi
from
New York, NY
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
New York Presbyterian-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Wake Heart Research (Rex Hospital)
mi
from
Raleigh, NC
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Wake Heart Research (Rex Hospital)
mi
from
Raleigh, NC
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Ohio Health Research Institute
mi
from
Columbus, OH
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Ohio Health Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated:  2/27/2018
Peoria Radiology Associates
mi
from
Peoria, IL
FORMAT Clinical Study
Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent
Status: Enrolling
Updated: 2/27/2018
Peoria Radiology Associates
mi
from
Peoria, IL
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
Keck Medical Center of USC
mi
from
Los Angeles, CA
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
Keck Medical Center of USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
Miami Cardiac and Vascular Institute
mi
from
Miami, FL
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
Miami Cardiac and Vascular Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
Good Samaritan Hospital
mi
from
Cincinnati, OH
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
Miami Valley Hospital
mi
from
Dayton, OH
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
Methodist Hospital
mi
from
Houston, TX
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated:  2/27/2018
University Hospital of Strasbourg
mi
from
Strasbourg,
Registry of the Magellan Robotic System
The Robotic Vascular and Endovascular Registry (ROVER)
Status: Enrolling
Updated: 2/27/2018
University Hospital of Strasbourg
mi
from
Strasbourg,
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of California-Davis
mi
from
Sacramento, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of Florida
mi
from
Gainesville, FL
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Eastern Idaho Regional Medical Center
mi
from
Idaho Falls, ID
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Eastern Idaho Regional Medical Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Northwestern University
mi
from
Chicago, IL
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials